A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 28, 2009

Viral Load Tied to Kidney Function

As viral load increases so does the risk of kidney problems, according to a study published in the June 1 issue of AIDS and reported by aidsmap. Fortunately, with decreases in viral load and increases in CD4 cells resulting from antiretroviral (ARV) treatment, kidney function is likely to improve.  

Studies show that kidney failure and reduced kidney function are more likely among people living with HIV than their HIV-negative peers. Though some ARV treatments—notably tenofovir (found in Viread, Truvada and Atripla)—are associated with potential kidney problems, researchers are still working out the specific factors associated with kidney disorders in HIV.

One such effort was undertaken by Chris Longenecker, MD, from the University of California in San Francisco, and his colleagues, who analyzed a group of 554 HIV-positive patients and 230 HIV-negative individuals participating in the Fat Redistribution and Metabolic Change in HIV infection (FRAM) study. Overall, Longenecker and his colleagues found that kidney function was much more variable in people with HIV than in HIV-negative patients. While HIV-positive patients were twice as likely to see reductions in their kidney function, they were also seven times more likely to see improvements as well. Also, people who had increases in their CD4 counts were likely to have improvements in kidney function.

When the researchers looked at the specific factors affecting kidney function, they found that an increase in viral load was tied to a reduction in kidney function, while significant viral load reductions in response to ARV treatment were associated with improvements in kidney function. Also, people who had a higher viral load at the start of the study were more likely to see a decline in kidney function.

“Our results suggest that HIV viral replication is a primary pathogenic factor in the development of kidney disease in HIV-infected persons and a potential therapeutic target for HIV-related kidney disease,” Longenecker’s group concludes.

Search: Kidney function, createnine, Cystatin C, kidney failure, Chris Longenecker


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

Mike, Saint Petersburg, 2009-06-03 07:57:01
Yawn. The next study will show how people on HIV antivirals are at high risk of kidney problems or failure because of toxicity. Then the next study will show how laying in the sun for 20 minutes twice a week is great for kidney, followed by a study showing that laying in the sun increases cancer risk 10 fold for HIV over non HIV

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    cindeelouwho
    Arlington
    Texas


    sevane
    Los Angeles
    California


    jonjonhg
    nyc
    New York


    SpizzleD6977
    White Lake
    Michigan
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.